Advertisement
Screener

Kynam Capital Management, LP Historic Quarter Change: USA Other Stocks, Added

Kynam Capital Management, LP historic quarter change: USA Other Stocks, Added

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Kynam Capital Management, LP opened 0 positions, added to 8, reduced 5 and sold out of 5.

  • Q1 2025: Stock SUTRO BIOPHARMA INC; Country of operation United States; Class COM; Shares before 3,641,447.
  • Q4 2024: Stock SUTRO BIOPHARMA INC; Country of operation United States; Class COM; Shares before 2,066,447.
  • Q3 2024: Stock WAVE LIFE SCIENCES LTD; Country of operation —; Class SHS; Shares before 3,975,521.
  • Q3 2024: Stock SUTRO BIOPHARMA INC; Country of operation United States; Class COM; Shares before 2,023,683.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1907884), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2021-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2025SUTRO BIOPHARMA INC
CUSIP 869367102
United StatesCOM3,641,4475,441,447+1,800,000$6,700,262$3,540,205-$3,160,0572025-05-15
Q4 2024SUTRO BIOPHARMA INC
CUSIP 869367102
United StatesCOM2,066,4473,641,447+1,575,000$7,149,907$6,700,262-$449,6452025-02-14
Q3 2024WAVE LIFE SCIENCES LTD
CUSIP Y95308105
SHS3,975,5214,899,497+923,976$19,837,850$40,175,875+$20,338,0252024-11-14
Q3 2024SUTRO BIOPHARMA INC
CUSIP 869367102
United StatesCOM2,023,6832,066,447+42,764$5,929,391$7,149,907+$1,220,5162024-11-14
Q3 2024ACELYRIN INC
CUSIP 00445A100
United StatesCOM831,310847,366+16,056$3,666,077$4,177,514+$511,4372024-11-14
Q2 2024SUTRO BIOPHARMA INC
CUSIP 869367102
United StatesCOM2,001,7272,023,683+21,956$11,309,758$5,929,391-$5,380,3672024-08-14
Q2 2024WAVE LIFE SCIENCES LTD
CUSIP Y95308105
SHS3,932,0823,975,521+43,439$24,260,946$19,837,850-$4,423,0962024-08-14
Q2 2024ACELYRIN INC
CUSIP 00445A100
United StatesCOM396,379831,310+434,931$2,675,558$3,666,077+$990,5192024-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
INVICTUS PRIVATE WEALTH, LLCUnited States$1.622B85
WOODMONT INVESTMENT COUNSEL LLCUnited States$1.622B263
HSG Holding LtdHong Kong$1.620B26
True Link Financial Advisors, LLCUnited States$1.619B418
Kathmere Capital Management, LLCUnited States$1.624B629
Pine Ridge Advisers LLCUnited States$1.624B41
BROWNING WEST LPUnited States$1.617B5
Covalis Capital LLPUnited Kingdom$1.626B123
Legacy Private Trust Co.United States$1.626B361
Granite Investment Partners, LLCUnited States$1.626B263